Shilpa Medicare, 530549, SHILPAMED Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,561.48
91.93
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,282.47
0.27%
1.98

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.97
2.95
7.11

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.89
1.22
2.20

PAT CAGR (%)

10 Years
5 Years
3 Years

13.75
5.63
7.52

P:E (Median)

8 Years
5 Years
3 Years

33.58
27.43
24.57

P:BV (Average)

8 Years
5 Years
3 Years

4.08
3.03
2.52

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.56
20.48
20.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 72.87 55.87 30.43% 276.64 171.30 61.49% 285.87 262.68 8.83% 240.33 216.64 10.94%
Expenses 74.42 63.36 17.46% 220.10 140.61 56.53% 221.94 181.30 22.42% 199.98 139.05 43.82%
EBITDA -1.55 -7.48 - 56.54 30.69 84.23% 63.93 81.38 -21.44% 40.34 77.59 -48.01%
EBIDTM -2.12% -13.39% 20.44% 17.92% 22.36% 30.98% 16.79% 35.81%
Other Income 10.34 31.33 -67.00% 13.00 8.61 50.99% 9.11 7.52 21.14% 9.79 2.64 270.83%
Interest 1.73 1.62 6.79% 6.60 3.95 67.09% 7.85 3.34 135.03% 6.99 3.54 97.46%
Depreciation 10.29 6.73 52.90% 14.61 10.48 39.41% 13.13 9.84 33.43% 11.69 9.91 17.96%
PBT -3.34 15.50 - 48.34 24.87 94.37% 60.98 75.72 -19.47% 31.46 119.72 -73.72%
Tax -0.39 5.49 - 11.58 7.99 44.93% 17.36 20.95 -17.14% 6.31 33.58 -81.21%
PAT -2.95 10.01 - 36.76 16.88 117.77% 43.62 54.78 -20.37% 25.15 86.14 -70.80%
PATM -4.04% 17.91% 13.29% 9.85% 15.26% 20.85% 10.46% 39.76%
EPS -0.34 1.15 - 4.24 1.94 118.56% 5.03 6.31 -20.29% 2.90 9.92 -70.77%

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 340.59 208.03 63.72% 272.30 191.25 42.38% 295.27 278.94 5.85% 237.36 222.87 6.50%
Expenses 266.87 181.82 46.78% 227.21 170.28 33.43% 242.11 210.25 15.15% 205.48 157.11 30.79%
EBITDA 73.73 26.21 181.30% 45.09 20.97 115.02% 53.16 68.68 -22.60% 31.88 65.75 -51.51%
EBIDTM 21.65% 12.60% 16.56% 10.96% 18.00% 24.62% 13.43% 29.50%
Other Income 5.49 6.91 -20.55% 5.48 8.61 -36.35% 1.28 9.20 -86.09% 1.99 5.48 -63.69%
Interest 9.35 9.12 2.52% 9.92 4.80 106.67% 11.58 3.95 193.16% 10.32 4.00 158.00%
Depreciation 22.34 15.23 46.68% 20.65 13.72 50.51% 19.18 12.70 51.02% 17.63 12.33 42.98%
PBT 47.41 8.76 441.21% 20.00 11.05 81.00% 32.59 61.23 -46.77% 5.92 115.74 -94.89%
Tax 16.86 0.80 2,007.50% 9.71 2.92 232.53% 11.56 15.99 -27.70% 3.56 29.14 -87.78%
PAT 30.55 7.96 283.79% 10.29 8.14 26.41% 21.03 45.24 -53.51% 2.36 86.60 -97.27%
PATM 8.97% 3.83% 3.78% 4.25% 7.12% 16.22% 1.00% 38.86%
EPS 3.40 0.96 254.17% 1.10 0.94 17.02% 2.45 5.57 -56.01% 0.19 10.59 -98.21%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 875.71 830.32 805.97 663.88 741.29 733.67 675.79 565.40 527.37 328.20 279.76 Net Sales Growth 23.95% 3.02% 21.40% -10.44% 1.04% 8.56% 19.52% 7.21% 60.69% 17.31% Cost Of Goods Sold 292.92 246.88 258.38 229.62 348.45 365.75 359.49 309.52 305.03 205.00 174.56 Gross Profit 582.79 583.43 547.60 434.26 392.85 367.92 316.30 255.88 222.34 123.19 105.20 GP Margin 66.55% 70.27% 67.94% 65.41% 53.00% 50.15% 46.80% 45.26% 42.16% 37.54% 37.60% Total Expenditure 716.44 613.43 568.18 494.86 573.43 560.97 511.35 431.01 409.65 262.79 223.47 Power & Fuel Cost - 36.22 35.31 31.39 27.00 24.56 20.54 17.58 15.55 8.83 7.63 % Of Sales - 4.36% 4.38% 4.73% 3.64% 3.35% 3.04% 3.11% 2.95% 2.69% 2.73% Employee Cost - 175.62 149.28 124.66 113.29 91.53 67.27 56.49 42.13 22.76 16.94 % Of Sales - 21.15% 18.52% 18.78% 15.28% 12.48% 9.95% 9.99% 7.99% 6.93% 6.06% Manufacturing Exp. - 83.29 75.34 55.63 55.48 50.58 42.10 29.78 22.80 13.28 10.20 % Of Sales - 10.03% 9.35% 8.38% 7.48% 6.89% 6.23% 5.27% 4.32% 4.05% 3.65% General & Admin Exp. - 33.88 24.76 16.55 12.15 11.52 9.00 6.57 6.41 7.67 6.45 % Of Sales - 4.08% 3.07% 2.49% 1.64% 1.57% 1.33% 1.16% 1.22% 2.34% 2.31% Selling & Distn. Exp. - 20.48 10.04 6.51 6.00 4.51 7.24 5.83 7.22 4.11 3.03 % Of Sales - 2.47% 1.25% 0.98% 0.81% 0.61% 1.07% 1.03% 1.37% 1.25% 1.08% Miscellaneous Exp. - 17.05 15.07 30.50 11.06 12.52 5.71 5.25 10.51 1.12 3.03 % Of Sales - 2.05% 1.87% 4.59% 1.49% 1.71% 0.84% 0.93% 1.99% 0.34% 1.67% EBITDA 159.26 216.89 237.79 169.02 167.86 172.70 164.44 134.39 117.72 65.41 56.29 EBITDA Margin 18.19% 26.12% 29.50% 25.46% 22.64% 23.54% 24.33% 23.77% 22.32% 19.93% 20.12% Other Income 42.24 44.02 40.02 17.16 34.52 29.82 11.14 7.51 8.85 5.01 7.79 Interest 23.17 17.47 4.33 2.79 2.12 2.79 3.27 3.88 3.40 1.95 1.97 Depreciation 49.72 40.85 34.96 34.01 32.78 26.66 21.19 19.09 21.09 12.75 11.44 PBT 137.44 202.59 238.53 149.38 167.49 173.08 151.12 118.93 102.08 55.72 50.66 Tax 34.86 71.15 40.27 31.49 34.25 41.09 35.84 34.84 21.23 9.65 11.54 Tax Rate 25.36% 27.84% 17.21% 20.24% 20.45% 24.38% 24.10% 29.29% 20.80% 17.35% 22.50% PAT 102.58 184.39 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 PAT before Minority Interest 102.58 184.39 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.71% 22.21% 24.04% 18.69% 17.97% 17.37% 16.70% 14.87% 15.33% 14.00% 14.21% PAT Growth -38.87% -4.82% 56.09% -6.85% 4.54% 12.93% 34.20% 4.01% 75.94% 15.62% EPS 11.82 21.24 22.32 14.30 15.35 14.68 13.00 9.69 9.32 5.29 4.58

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 1,145.52 901.13 907.91 733.39 788.83 779.16 716.43 613.80 571.38 371.32 318.18 Net Sales Growth 27.13% -0.75% 23.80% -7.03% 1.24% 8.76% 16.72% 7.42% 53.88% 16.70% Cost Of Goods Sold 383.22 270.73 277.73 257.03 355.87 371.81 366.19 323.16 313.26 213.95 183.22 Gross Profit 762.30 630.40 630.18 476.36 432.95 407.36 350.25 290.63 258.12 157.38 134.96 GP Margin 66.55% 69.96% 69.41% 64.95% 54.89% 52.28% 48.89% 47.35% 45.17% 42.38% 42.42% Total Expenditure 941.67 729.42 693.39 579.39 637.60 617.55 556.44 487.38 455.40 301.63 257.08 Power & Fuel Cost - 40.25 38.76 33.57 28.86 26.30 21.90 19.29 17.37 10.67 9.38 % Of Sales - 4.47% 4.27% 4.58% 3.66% 3.38% 3.06% 3.14% 3.04% 2.87% 2.95% Employee Cost - 235.31 196.59 176.40 149.35 127.87 90.09 82.30 67.83 42.56 33.68 % Of Sales - 26.11% 21.65% 24.05% 18.93% 16.41% 12.57% 13.41% 11.87% 11.46% 10.59% Manufacturing Exp. - 88.99 79.19 61.23 59.96 52.55 45.35 36.55 27.44 16.92 12.89 % Of Sales - 9.88% 8.72% 8.35% 7.60% 6.74% 6.33% 5.95% 4.80% 4.56% 4.05% General & Admin Exp. - 47.67 70.26 27.20 22.50 16.95 14.11 10.64 9.53 9.51 7.87 % Of Sales - 5.29% 7.74% 3.71% 2.85% 2.18% 1.97% 1.73% 1.67% 2.56% 2.47% Selling & Distn. Exp. - 20.79 10.40 6.72 6.37 4.75 7.27 5.99 7.29 4.43 3.19 % Of Sales - 2.31% 1.15% 0.92% 0.81% 0.61% 1.01% 0.98% 1.28% 1.19% 1.00% Miscellaneous Exp. - 25.68 20.47 17.23 14.68 17.32 11.54 9.45 12.68 3.59 3.19 % Of Sales - 2.85% 2.25% 2.35% 1.86% 2.22% 1.61% 1.54% 2.22% 0.97% 2.16% EBITDA 203.86 171.71 214.52 154.00 151.23 161.61 159.99 126.42 115.98 69.69 61.10 EBITDA Margin 17.80% 19.05% 23.63% 21.00% 19.17% 20.74% 22.33% 20.60% 20.30% 18.77% 19.20% Other Income 14.24 40.09 22.22 15.56 32.62 29.34 11.36 6.93 9.12 5.01 8.28 Interest 41.17 21.87 4.56 3.68 2.66 3.13 3.93 4.05 3.52 2.27 2.31 Depreciation 79.80 53.98 43.78 42.06 37.22 30.64 23.14 21.41 23.22 15.34 14.36 PBT 105.92 135.95 188.40 123.82 143.96 157.17 144.28 107.89 98.35 57.10 52.71 Tax 41.69 48.85 33.49 26.18 33.91 42.04 35.62 35.22 20.30 9.53 12.22 Tax Rate 39.36% 24.82% 17.78% 18.22% 23.56% 27.54% 25.11% 32.66% 21.27% 16.72% 22.91% PAT 64.23 149.52 156.50 120.28 112.43 113.71 109.84 73.69 75.67 47.35 41.23 PAT before Minority Interest 64.30 147.94 154.91 117.52 110.05 110.59 106.24 72.62 75.15 47.47 41.11 Minority Interest 0.07 1.58 1.59 2.76 2.38 3.12 3.60 1.07 0.52 -0.12 0.12 PAT Margin 5.61% 16.59% 17.24% 16.40% 14.25% 14.59% 15.33% 12.01% 13.24% 12.75% 12.96% PAT Growth -56.58% -4.46% 30.11% 6.98% -1.13% 3.52% 49.06% -2.62% 59.81% 14.84% EPS 7.40 17.23 18.03 13.86 12.95 13.10 12.65 8.49 8.72 5.46 4.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 1,637.83 1,453.42 1,281.55 1,156.98 1,029.62 664.59 563.10 412.56 330.79 287.30 Share Capital 8.15 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 Total Reserves 1,629.68 1,445.27 1,273.39 1,148.83 1,021.60 656.88 555.39 405.21 325.88 282.39 Non-Current Liabilities 412.11 208.00 157.15 139.08 241.14 59.29 59.43 65.23 64.16 24.94 Secured Loans 330.77 164.48 80.39 67.08 141.18 0.00 16.23 37.38 43.22 5.07 Unsecured Loans 0.00 0.00 0.70 1.03 1.30 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 13.76 8.72 5.36 5.08 5.55 4.32 3.89 0.88 0.31 0.76 Current Liabilities 467.45 359.86 229.59 251.05 219.71 205.32 160.13 149.05 111.97 109.74 Trade Payables 56.91 76.63 71.37 98.86 103.91 98.20 65.58 86.61 47.74 53.13 Other Current Liabilities 159.46 119.85 76.53 56.68 25.20 25.74 38.28 35.64 21.51 18.28 Short Term Borrowings 241.90 156.40 78.72 92.95 88.04 69.59 50.84 22.02 38.92 35.73 Short Term Provisions 9.18 6.97 2.97 2.57 2.55 11.79 5.43 4.78 3.80 2.60 Total Liabilities 2,517.39 2,021.28 1,668.29 1,547.11 1,490.47 929.20 782.66 626.84 506.92 421.98 Net Block 640.90 517.00 510.84 488.69 448.85 349.77 280.01 257.66 152.56 140.84 Gross Block 918.48 756.00 723.32 666.58 594.31 469.21 378.74 338.75 212.70 188.18 Accumulated Depreciation 277.58 238.99 212.49 177.89 145.46 119.44 98.73 81.09 60.14 47.34 Non Current Assets 1,737.15 1,113.59 1,147.87 893.90 786.14 597.17 497.66 402.49 324.23 246.74 Capital Work in Progress 482.35 372.81 401.21 200.99 136.51 89.38 87.71 49.24 114.27 55.27 Non Current Investment 219.32 93.48 89.04 111.35 101.78 94.05 74.24 65.07 37.01 33.11 Long Term Loans & Adv. 391.84 124.54 119.95 68.04 94.26 58.65 55.60 30.48 19.99 17.18 Other Non Current Assets 2.76 5.76 26.83 24.83 4.75 5.31 0.08 0.05 0.40 0.34 Current Assets 780.24 907.69 520.42 653.22 704.32 332.03 284.99 224.36 182.69 175.24 Current Investments 0.00 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 Inventories 299.08 206.23 176.70 167.72 174.96 124.66 120.88 108.95 66.13 59.87 Sundry Debtors 218.27 226.54 181.68 218.14 166.50 111.98 70.12 60.31 31.88 33.19 Cash & Bank 115.27 28.19 90.93 73.14 93.10 5.66 2.49 0.81 10.53 1.95 Other Current Assets 147.62 416.56 55.40 28.59 45.15 30.11 26.15 44.15 23.87 12.22 Short Term Loans & Adv. 48.10 30.17 15.70 46.09 21.91 15.56 4.95 26.77 12.66 5.71 Net Current Assets 312.79 547.83 290.83 402.16 484.62 126.71 124.87 75.31 70.72 65.50 Total Assets 2,517.39 2,021.28 1,668.29 1,547.12 1,490.46 929.20 782.65 626.85 506.92 421.98

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 1,478.67 1,329.36 1,197.58 1,085.03 986.90 639.26 546.94 396.45 320.42 275.98 Share Capital 8.15 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 Total Reserves 1,470.51 1,321.21 1,189.43 1,076.88 978.88 631.55 539.23 389.09 315.52 271.07 Non-Current Liabilities 567.90 256.94 166.62 153.48 251.26 67.23 154.15 104.53 98.51 31.13 Secured Loans 480.12 164.48 80.39 67.09 141.20 0.03 71.03 37.43 70.47 5.07 Unsecured Loans 0.35 0.53 0.70 1.03 1.30 0.00 31.30 30.05 0.00 0.00 Long Term Provisions 15.48 26.17 21.77 20.32 16.89 13.96 11.75 9.93 6.92 6.34 Current Liabilities 602.16 410.82 253.44 265.84 236.90 222.07 189.06 166.84 123.77 121.14 Trade Payables 72.15 92.55 80.72 103.74 111.86 106.48 75.50 92.98 51.26 56.72 Other Current Liabilities 275.30 142.10 81.62 59.59 28.03 36.49 49.32 38.23 23.38 20.34 Short Term Borrowings 243.40 165.27 86.58 98.12 92.41 74.10 58.47 30.27 45.07 41.24 Short Term Provisions 11.31 10.89 4.52 4.39 4.60 5.00 5.77 5.37 4.06 2.83 Total Liabilities 2,637.56 1,989.21 1,610.02 1,499.13 1,472.22 930.89 904.54 677.83 551.42 433.11 Net Block 1,110.53 650.44 558.01 534.20 491.93 393.41 316.06 294.42 180.67 166.61 Gross Block 1,421.35 986.42 853.16 793.24 704.89 582.20 476.34 448.38 300.89 271.30 Accumulated Depreciation 310.81 335.98 295.15 259.04 212.96 188.79 160.28 153.96 120.22 104.70 Non Current Assets 1,719.50 1,365.35 1,064.96 827.16 742.33 576.68 576.77 443.89 339.18 244.95 Capital Work in Progress 541.29 666.25 429.12 209.85 140.51 91.90 221.62 111.03 129.15 57.71 Non Current Investment 21.22 10.45 2.25 20.79 27.99 34.15 0.19 0.21 0.14 0.11 Long Term Loans & Adv. 43.35 32.42 48.75 37.47 77.09 51.86 38.74 38.18 28.82 20.17 Other Non Current Assets 3.11 5.78 26.84 24.86 4.80 5.36 0.16 0.06 0.40 0.34 Current Assets 918.05 623.85 545.06 671.97 729.88 354.21 327.61 233.74 211.99 187.87 Current Investments 0.00 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 Inventories 316.84 226.43 187.67 188.71 190.00 134.23 130.78 123.25 74.33 67.32 Sundry Debtors 222.69 246.79 203.73 220.27 170.93 125.43 81.37 67.96 41.79 40.53 Cash & Bank 123.11 44.56 94.54 73.83 100.39 11.03 18.42 9.19 16.87 2.27 Other Current Assets 255.42 76.81 45.04 26.08 43.95 23.90 31.69 23.20 28.72 9.72 Short Term Loans & Adv. 74.01 29.25 14.08 43.54 21.95 8.90 4.91 3.23 2.86 3.01 Net Current Assets 315.89 213.04 291.62 406.13 492.98 132.14 138.55 66.90 88.22 66.73 Total Assets 2,637.55 1,989.20 1,610.02 1,499.13 1,472.21 930.89 904.54 677.83 551.42 433.10

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 80.71 129.79 164.16 54.46 50.49 119.65 67.35 58.99 35.95 49.57 PBT 255.54 233.99 155.60 167.49 168.53 148.70 118.93 102.08 55.61 51.29 Adjustment -25.46 -5.39 25.78 8.68 15.28 18.05 22.61 16.42 8.34 7.28 Changes in Working Capital -106.02 -57.95 18.23 -81.25 -99.93 -15.54 -49.19 -38.22 -17.11 -1.22 Cash after chg. in Working capital 124.05 170.65 199.61 94.92 83.89 151.21 92.35 80.29 46.84 57.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -43.34 -40.85 -35.45 -40.45 -33.40 -31.55 -25.01 -21.30 -10.89 -7.78 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -249.21 -295.10 -214.71 -12.83 -274.78 -100.98 -139.48 -38.20 -63.04 -144.57 Net Fixed Assets -272.02 -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 Net Investments -125.84 -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 Others 148.65 -286.38 -99.60 28.41 70.17 5.25 3.36 10.74 6.64 7.68 Cash from Financing Activity 255.58 170.10 8.17 -61.16 315.27 -14.58 73.82 -30.51 35.67 12.99 Net Cash Inflow / Outflow 87.08 4.80 -42.38 -19.53 90.98 4.09 1.69 -9.72 8.58 -82.01 Opening Cash & Equivalents 27.94 30.53 73.14 92.68 1.70 -3.02 0.81 10.53 1.95 83.96 Closing Cash & Equivalent 115.01 27.94 30.76 73.14 92.68 1.07 2.49 0.81 10.53 1.95

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 47.07 124.38 146.78 44.92 37.48 128.70 68.81 70.04 43.64 56.73 PBT 196.79 188.40 143.70 136.77 146.49 140.36 107.84 95.45 57.00 53.51 Adjustment 4.17 41.32 20.44 18.83 17.19 20.61 26.46 19.62 11.52 10.19 Changes in Working Capital -106.29 -63.15 18.71 -69.66 -92.61 -2.70 -40.11 -23.44 -13.90 0.77 Cash after chg. in Working capital 94.67 166.57 182.85 85.94 71.08 158.27 94.19 91.62 54.62 64.46 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -47.60 -42.20 -36.07 -41.02 -33.60 -29.56 -25.38 -21.58 -10.98 -7.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -404.28 -289.52 -196.16 -8.76 -262.23 -109.20 -195.18 -48.93 -95.21 -152.31 Net Fixed Assets -272.02 -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 Net Investments -125.84 -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 Others -6.42 -280.80 -81.05 32.48 82.72 -2.97 -52.34 0.01 -25.53 -0.06 Cash from Financing Activity 436.37 175.50 10.06 -60.91 312.70 -19.65 135.05 -28.34 66.31 10.02 Net Cash Inflow / Outflow 79.17 10.36 -39.32 -24.75 87.95 -0.15 8.68 -7.23 14.74 -85.56 Opening Cash & Equivalents 44.31 34.13 73.83 99.97 7.05 3.61 9.19 16.87 2.27 87.83 Closing Cash & Equivalent 123.34 44.31 34.36 73.83 99.97 6.43 18.42 9.19 16.87 2.27

Financial Ratios

Consolidated /

Standalone

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 200.89 178.27 157.19 141.91 128.50 86.20 73.03 112.15 89.92 78.10 ROA 8.13% 10.50% 7.72% 8.77% 10.53% 13.19% 11.93% 14.26% 9.90% 10.56% ROE 11.93% 14.17% 10.18% 12.19% 15.05% 18.39% 17.24% 21.75% 14.87% 15.34% ROCE 13.24% 14.44% 11.27% 13.00% 16.98% 21.70% 21.49% 22.89% 14.93% 16.97% Fixed Asset Turnover 0.99 1.09 0.96 1.18 1.39 1.61 1.59 1.94 1.67 1.62 Receivable days 97.77 92.44 109.91 94.36 68.87 48.77 41.69 31.48 35.42 42.78 Inventory Days 111.07 86.71 94.68 84.06 74.10 65.76 73.47 59.79 68.58 62.31 Payable days 98.72 46.77 62.82 63.90 61.73 57.90 62.98 59.11 68.15 62.12 Cash Conversion Cycle 110.12 132.38 141.78 114.52 81.24 56.63 52.19 32.17 35.85 42.98 Total Debt/Equity 0.40 0.26 0.15 0.16 0.23 0.13 0.15 0.19 0.30 0.19 Interest Cover 15.63 55.05 56.69 79.92 61.31 46.45 31.65 31.05 29.59 27.03

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 181.37 163.06 146.89 133.09 123.17 82.91 70.92 107.72 43.52 74.94 ROA 6.39% 8.61% 7.56% 7.41% 9.20% 11.58% 9.18% 12.23% 9.64% 10.66% ROE 10.54% 12.26% 10.30% 10.62% 13.60% 17.92% 15.40% 20.98% 15.93% 16.63% ROCE 10.82% 12.41% 11.05% 11.71% 15.91% 19.90% 17.90% 20.48% 15.04% 18.02% Fixed Asset Turnover 0.75 0.99 0.89 1.06 1.22 1.36 1.34 1.54 1.32 1.28 Receivable days 95.08 90.56 105.51 90.20 69.00 52.26 43.99 34.62 39.70 45.47 Inventory Days 110.03 83.24 93.66 87.32 75.49 66.97 74.84 62.33 68.31 62.38 Payable days 111.02 47.69 58.00 61.51 60.89 60.10 62.86 57.06 63.94 59.10 Cash Conversion Cycle 94.09 126.11 141.17 116.00 83.61 59.13 55.97 39.90 44.07 48.76 Total Debt/Equity 0.57 0.29 0.16 0.18 0.24 0.14 0.34 0.30 0.41 0.22 Interest Cover 10.00 42.34 40.09 55.10 49.69 37.07 27.63 28.09 26.13 24.13

Top Investors:

ta fii investors limited

pivotal enterprises private limited

pivotal business managers llp

think india opportunities master fund lp

blue daimond properties pvt ltd

malabar select fund

malabar india fund limited

india opportunities growth fund ltd - pinewood str

sundar iyer

anandkumar ramesh gupta

Annual Reports:

News Update:

USFDA inspects Shilpa Medicare’s Analytical Services Division in Telangana
2nd May 2022, 16:30 PM

The inspection has been closed with four observations, which are related to improvements in existing procedures and are addressable
Read More
Shilpa Medicare gets NoC from RCGM for Biosimilar Aflibercept
26th Apr 2022, 10:49 AM

The product is a biosimilar version of EYLEA of Regeneron for which currently there is no other biosimilar version on the Indian market
Read More

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: